Fall Seed Grant CBLC Call for Research on Rare Diseases (Italy)

The Fall Seed Grant 2026, offered by Fondazione Telethon in collaboration with Patient Associations, is now accepting applications. This initiative funds single-center research projects that focus on rare genetic disorders, specifically Methylmalonic acidemia with homocystinuria, type cblC, and SLC6A1-Related Neurodevelopmental Disorder. The application deadline is 16 November 2026. The Fall Seed Grant 2026 aims to support innovative research projects that generate new knowledge and data for rare genetic disorders. The initiative is a collaboration between Fondazione Telethon and patient associations, specifically targeting Methylmalonic acidemia with homocystinuria, type cblC, and SLC6A1-Related Neurodevelopmental Disorder. This grant provides crucial funding to foster the development of therapeutic approaches for rare genetic diseases. By supporting research in these specific disorders, the initiative helps in paving the way for potential breakthroughs in treatment and understanding of these conditions. What is the maximum funding available per project? The maximum funding is €75,000 for Methylmalonic acidemia projects and €50,000 for SLC6A1-Related Neurodevelopmental Disorder projects. Who can apply for this grant? Researchers working at Italian non-profit research institutions are eligible to apply. What are the project durations? 18 months for Methylmalonic acidemia projects and 12 months for SLC6A1-Related Neurodevelopmental Disorder projects. Is registration on the platform mandatory? Registration is encouraged but not mandatory. What is the deadline for application submission?

16 November 2026, at 1: 00 PM (CEST).

Eligible researchers should review the official guidelines and follow the application process through the provided link. Ensure all documentation is complete and submitted before the deadline.